US Stock MarketDetailed Quotes

RSLS ReShape Lifesciences

Watchlist
  • 4.3800
  • -0.0900-2.01%
Close Dec 20 16:00 ET
  • 4.3800
  • 0.00000.00%
Post 20:01 ET
3.12MMarket Cap-0.44P/E (TTM)

ReShape Lifesciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
6.36%2.29M
-12.82%1.97M
-15.00%1.94M
-22.79%8.68M
-36.27%1.98M
-22.98%2.16M
-22.06%2.25M
-6.27%2.29M
-17.35%11.24M
-1.02%3.11M
Operating revenue
6.36%2.29M
-12.82%1.97M
-15.00%1.94M
-22.79%8.68M
-36.27%1.98M
-22.98%2.16M
-22.06%2.25M
-6.27%2.29M
-17.35%11.24M
-1.02%3.11M
Cost of revenue
-1.61%853K
-21.60%831K
-26.72%779K
-29.47%3.13M
-90.73%140K
24.39%867K
5.05%1.06M
-13.01%1.06M
-15.50%4.44M
10.54%1.51M
Gross profit
11.72%1.44M
-5.03%1.13M
-4.82%1.17M
-18.44%5.55M
15.13%1.84M
-38.70%1.29M
-36.59%1.19M
0.49%1.22M
-18.52%6.8M
-9.91%1.6M
Operating expense
-27.12%3.2M
-38.73%3.19M
-50.77%3.38M
-40.42%20.19M
-45.30%3.74M
-37.02%4.39M
-51.58%5.2M
-26.54%6.86M
-4.78%33.88M
-15.29%6.83M
Selling and administrative expenses
-27.23%2.8M
-39.66%2.79M
-54.84%2.89M
-42.98%17.87M
-52.94%3M
-39.76%3.85M
-53.78%4.62M
-25.44%6.4M
-5.63%31.34M
-19.78%6.37M
-Selling and marketing expense
-59.85%719K
-69.22%670K
-53.30%1.02M
-46.44%7.55M
-35.19%1.4M
-31.25%1.79M
-53.04%2.18M
-53.52%2.18M
58.47%14.09M
-20.32%2.16M
-General and administrative expense
1.17%2.08M
-13.33%2.12M
-55.64%1.87M
-40.15%10.32M
-62.02%1.6M
-45.61%2.06M
-54.41%2.45M
8.43%4.22M
-29.07%17.25M
-19.51%4.21M
Research and development costs
-26.38%399K
-31.33%399K
6.84%484K
-8.75%2.32M
59.96%739K
-7.03%542K
-22.22%581K
-39.19%453K
7.09%2.54M
272.58%462K
Operating profit
43.25%-1.76M
48.77%-2.05M
60.75%-2.21M
45.94%-14.64M
63.78%-1.9M
36.30%-3.1M
54.77%-4.01M
30.59%-5.63M
0.57%-27.08M
16.81%-5.23M
Net non-operating interest income expense
0
-55.56%4K
280.00%9K
123.01%26K
110.63%17K
-83.87%5K
-35.71%9K
-600.00%-5K
86.42%-113K
-471.43%-160K
Non-operating interest income
--0
-55.56%4K
----
----
----
-83.87%5K
-35.71%9K
----
----
----
Total other finance cost
----
----
-280.00%-9K
-123.01%-26K
----
----
----
--5K
--113K
----
Other net income (expense)
142.96%186K
-8.02%470K
-99.26%22K
116.89%3.28M
101.90%211K
94.38%-433K
187.20%511K
10,966.67%2.99M
45.12%-19.4M
63.68%-11.13M
Gain on sale of security
-77.62%77K
-103.81%-18K
-100.10%-3K
2,865.96%3.9M
-70.25%97K
223.30%344K
331.37%472K
18,562.50%2.99M
94.67%-141K
16,400.00%326K
Special income (charges)
--0
1,200.00%429K
----
96.14%-744K
--0
89.54%-777K
108.66%33K
----
41.08%-19.27M
62.61%-11.46M
-Less:Impairment of capital assets
--0
----
----
-95.85%777K
--0
-89.54%777K
----
----
-38.84%18.74M
-63.08%11.32M
-Less:Other special charges
----
---429K
----
----
----
----
----
----
----
----
-Gain on sale of property,plant,equipment
--0
--0
----
106.24%33K
--0
--0
108.66%33K
----
---529K
---146K
Other non- operating income (expenses)
--109K
883.33%59K
1,150.00%25K
1,009.09%122K
5,600.00%114K
----
700.00%6K
-81.82%2K
--11K
--2K
Income before tax
55.40%-1.58M
54.71%-1.58M
17.71%-2.18M
75.67%-11.34M
89.91%-1.67M
71.86%-3.53M
63.02%-3.49M
67.25%-2.65M
26.53%-46.59M
55.30%-16.53M
Income tax
100.00%6K
275.00%15K
0.00%14K
113.68%52K
155.36%31K
100.83%3K
-55.56%4K
-53.33%14K
-38.69%-380K
81.14%-56K
Net income
55.26%-1.58M
54.34%-1.6M
17.62%-2.19M
75.36%-11.39M
89.69%-1.7M
71.00%-3.53M
63.01%-3.49M
67.20%-2.66M
26.81%-46.21M
55.09%-16.47M
Net income continuous Operations
55.26%-1.58M
54.34%-1.6M
17.62%-2.19M
75.36%-11.39M
89.69%-1.7M
71.00%-3.53M
63.01%-3.49M
67.20%-2.66M
26.81%-46.21M
55.09%-16.47M
Minority interest income
Net income attributable to the parent company
55.26%-1.58M
54.34%-1.6M
17.62%-2.19M
75.36%-11.39M
89.69%-1.7M
71.00%-3.53M
63.01%-3.49M
67.20%-2.66M
26.81%-46.21M
55.09%-16.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
55.26%-1.58M
54.34%-1.6M
17.62%-2.19M
75.36%-11.39M
89.69%-1.7M
71.00%-3.53M
63.01%-3.49M
67.20%-2.66M
26.81%-46.21M
55.09%-16.47M
Basic earnings per share
94.76%-3.11
94.44%-3.48
94.23%-5.22
98.25%-110.78
99.79%-4.1985
96.21%-59.36
95.58%-62.64
92.87%-90.48
62.31%-6.32K
65.86%-2.04K
Diluted earnings per share
94.76%-3.11
94.44%-3.48
94.23%-5.22
98.25%-110.78
99.79%-4.1985
96.21%-59.36
95.58%-62.64
92.87%-90.48
62.31%-6.32K
65.86%-2.04K
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 6.36%2.29M-12.82%1.97M-15.00%1.94M-22.79%8.68M-36.27%1.98M-22.98%2.16M-22.06%2.25M-6.27%2.29M-17.35%11.24M-1.02%3.11M
Operating revenue 6.36%2.29M-12.82%1.97M-15.00%1.94M-22.79%8.68M-36.27%1.98M-22.98%2.16M-22.06%2.25M-6.27%2.29M-17.35%11.24M-1.02%3.11M
Cost of revenue -1.61%853K-21.60%831K-26.72%779K-29.47%3.13M-90.73%140K24.39%867K5.05%1.06M-13.01%1.06M-15.50%4.44M10.54%1.51M
Gross profit 11.72%1.44M-5.03%1.13M-4.82%1.17M-18.44%5.55M15.13%1.84M-38.70%1.29M-36.59%1.19M0.49%1.22M-18.52%6.8M-9.91%1.6M
Operating expense -27.12%3.2M-38.73%3.19M-50.77%3.38M-40.42%20.19M-45.30%3.74M-37.02%4.39M-51.58%5.2M-26.54%6.86M-4.78%33.88M-15.29%6.83M
Selling and administrative expenses -27.23%2.8M-39.66%2.79M-54.84%2.89M-42.98%17.87M-52.94%3M-39.76%3.85M-53.78%4.62M-25.44%6.4M-5.63%31.34M-19.78%6.37M
-Selling and marketing expense -59.85%719K-69.22%670K-53.30%1.02M-46.44%7.55M-35.19%1.4M-31.25%1.79M-53.04%2.18M-53.52%2.18M58.47%14.09M-20.32%2.16M
-General and administrative expense 1.17%2.08M-13.33%2.12M-55.64%1.87M-40.15%10.32M-62.02%1.6M-45.61%2.06M-54.41%2.45M8.43%4.22M-29.07%17.25M-19.51%4.21M
Research and development costs -26.38%399K-31.33%399K6.84%484K-8.75%2.32M59.96%739K-7.03%542K-22.22%581K-39.19%453K7.09%2.54M272.58%462K
Operating profit 43.25%-1.76M48.77%-2.05M60.75%-2.21M45.94%-14.64M63.78%-1.9M36.30%-3.1M54.77%-4.01M30.59%-5.63M0.57%-27.08M16.81%-5.23M
Net non-operating interest income expense 0-55.56%4K280.00%9K123.01%26K110.63%17K-83.87%5K-35.71%9K-600.00%-5K86.42%-113K-471.43%-160K
Non-operating interest income --0-55.56%4K-------------83.87%5K-35.71%9K------------
Total other finance cost ---------280.00%-9K-123.01%-26K--------------5K--113K----
Other net income (expense) 142.96%186K-8.02%470K-99.26%22K116.89%3.28M101.90%211K94.38%-433K187.20%511K10,966.67%2.99M45.12%-19.4M63.68%-11.13M
Gain on sale of security -77.62%77K-103.81%-18K-100.10%-3K2,865.96%3.9M-70.25%97K223.30%344K331.37%472K18,562.50%2.99M94.67%-141K16,400.00%326K
Special income (charges) --01,200.00%429K----96.14%-744K--089.54%-777K108.66%33K----41.08%-19.27M62.61%-11.46M
-Less:Impairment of capital assets --0---------95.85%777K--0-89.54%777K---------38.84%18.74M-63.08%11.32M
-Less:Other special charges -------429K--------------------------------
-Gain on sale of property,plant,equipment --0--0----106.24%33K--0--0108.66%33K-------529K---146K
Other non- operating income (expenses) --109K883.33%59K1,150.00%25K1,009.09%122K5,600.00%114K----700.00%6K-81.82%2K--11K--2K
Income before tax 55.40%-1.58M54.71%-1.58M17.71%-2.18M75.67%-11.34M89.91%-1.67M71.86%-3.53M63.02%-3.49M67.25%-2.65M26.53%-46.59M55.30%-16.53M
Income tax 100.00%6K275.00%15K0.00%14K113.68%52K155.36%31K100.83%3K-55.56%4K-53.33%14K-38.69%-380K81.14%-56K
Net income 55.26%-1.58M54.34%-1.6M17.62%-2.19M75.36%-11.39M89.69%-1.7M71.00%-3.53M63.01%-3.49M67.20%-2.66M26.81%-46.21M55.09%-16.47M
Net income continuous Operations 55.26%-1.58M54.34%-1.6M17.62%-2.19M75.36%-11.39M89.69%-1.7M71.00%-3.53M63.01%-3.49M67.20%-2.66M26.81%-46.21M55.09%-16.47M
Minority interest income
Net income attributable to the parent company 55.26%-1.58M54.34%-1.6M17.62%-2.19M75.36%-11.39M89.69%-1.7M71.00%-3.53M63.01%-3.49M67.20%-2.66M26.81%-46.21M55.09%-16.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 55.26%-1.58M54.34%-1.6M17.62%-2.19M75.36%-11.39M89.69%-1.7M71.00%-3.53M63.01%-3.49M67.20%-2.66M26.81%-46.21M55.09%-16.47M
Basic earnings per share 94.76%-3.1194.44%-3.4894.23%-5.2298.25%-110.7899.79%-4.198596.21%-59.3695.58%-62.6492.87%-90.4862.31%-6.32K65.86%-2.04K
Diluted earnings per share 94.76%-3.1194.44%-3.4894.23%-5.2298.25%-110.7899.79%-4.198596.21%-59.3695.58%-62.6492.87%-90.4862.31%-6.32K65.86%-2.04K
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List